Encellin, a biotechnology company pioneering Encapsulated Cell Replacement Therapy (ENCRT), today announced interim clinical results from its ongoing Phase 1 investigational trial (NCT06408311) in ...

Antioxidants have long been regarded as key players in protecting cells and maintaining health, but a research team led by ...

A research team reports a promising new strategy: combining two already-approved drugs—silybin, a natural liver-protective compound, and carvedilol, a widely used cardiovascular medicine—to powerfully ...

Researchers at CSH Laboratory identified an oncogenic SRSF1–AURKA–MYC circuit driving pancreatic ductal adenocarcinoma.

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

Akadeum Life Sciences, the leader in buoyant microbubble cell separation, today announced that its Chief Executive Officer Brandon McNaughton, PhD, will present at Biotech Showcase (TM) 2026 in San ...

A combination of silybin and carvedilol for treating liver fibrosis is more effective than either drug alone. | Drug ...

The cell freezing media market plays a pivotal role in preserving stem cells, primary cells, and cell lines, enabling ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

San Diego, California, U.S.A.-based food tech startup BlueNalu announced it has garnered a USD 11 million (EUR 9.4 million) ...

The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035 ...